Our interdisciplinary teams of clinicians, nurses and researchers are committed to streamlining the process of translating discoveries into treatments and cures.
The Office of Technology Transfer is committed to this vision. It is our mission to maximize the impact of institutional innovations and research excellence by facilitating the translation and commercialization of scientific discoveries into accessible healthcare products and services that benefit patients worldwide.
Partner With Us
We Are Here to Build Mutually Beneficial Partnerships
Houston Methodist Hospital has a history of collaboration with corporations to leverage the hospital’s excellence in cutting-edge clinical research, technology development, and outreach to maximize opportunities that advance healthcare discoveries.
We can assist in facilitating discussions with our talented researchers and clinicians working in your areas of interest that could lead to partnerships and collaborations through commercialization or sponsored research.
If you are interested in exploring potential opportunities, contact us today - we look forward to talking to you.
232
22
2,340
Our Director
John is currently the Director for the Office of Technology Transfer at Houston Methodist Hospital and Research Institute. Previously, he was Acting Vice President of Business Development at Pharmozyme Inc., an engineered enzyme production platform company. Prior to that he was Vice President of Corporate Development at Intrexon Corporation where he led all corporate development activities supporting a portfolio of synthetic biology assets in the healthcare, food and industrial biotech sectors. He was also Director of Business Development at Roche Tissue Diagnostics and the Senior Vice President of Licensing and Strategic Development at Clinical Data Inc. a drug development (vilazodone) and laboratory services provider of patient testing and contract DNA sequencing services for pharma, which was acquired by Forest Laboratories. John has also worked in various general management, sales and marketing positions for BioChem Pharma and Sigma-Aldrich Chemical. He began his career as the Asia-Pacific Sales and Marketing Manager -- for Mallinckrodt. He joined the Office of Technology Transfer in 2016.
Director:
John A. Schultz, MBA, CLPDirector for the Office of Technology Transfer
News
For more information regarding licensing and partnership opportunities, call 713.441.6759